Welcome to LookChem.com Sign In|Join Free
  • or
4-(3-(tetrahydro-2H-pyran-4-yl)pyrazin-2-yloxy)aniline is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1227068-53-2

Post Buying Request

1227068-53-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1227068-53-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1227068-53-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,0,6 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1227068-53:
(9*1)+(8*2)+(7*2)+(6*7)+(5*0)+(4*6)+(3*8)+(2*5)+(1*3)=142
142 % 10 = 2
So 1227068-53-2 is a valid CAS Registry Number.

1227068-53-2Relevant academic research and scientific papers

PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

-

Page/Page column 183-184, (2010/06/15)

Pyrazine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

-

Page/Page column 149; 150, (2010/07/04)

Pyridine and pyrimidine compounds: or a pharmaceutically acceptable salt thereof, wherein m, n, R1, R2, R3, R4, R5, R6, R7, X1, X2, X3, X4, X5, X6, X7, X8, and Y are as defined in the specification; or a pharmaceutically acceptable salt thereof, wherein ring A, m, n, y, R2, R3, R4, R5, R6, R7, R8, R9, X1, X2, and ring A are as defined in the specification; and or a pharmaceutically acceptable salt thereof, wherein m, n, y, R2, R3, R4, R5, R6, R7, R9, X1, X2, and ring A are as defined in the specification; compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1227068-53-2